Yu Xia, Jiayu Zhong, Mingqi Zhao, Ying Tang, Ning Han, Liang Hua, . . . Bing Zhu. (2019). Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYu Xia, Jiayu Zhong, Mingqi Zhao, Ying Tang, Ning Han, Liang Hua, Tiantian Xu, Changbing Wang, and Bing Zhu. Galactose-modified Selenium Nanoparticles for Targeted Delivery of Doxorubicin to Hepatocellular Carcinoma. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationYu Xia, et al. Galactose-modified Selenium Nanoparticles for Targeted Delivery of Doxorubicin to Hepatocellular Carcinoma. Taylor & Francis Group, 2019.
Warning: These citations may not always be 100% accurate.